A Randomized, Parallel Group, Double-blind, Multi-center Study Comparing the Efficacy and Safety of AVANDAMET and Metformin After 80 Weeks of Treatment.
Phase of Trial: Phase IV
Latest Information Update: 17 Jul 2015
At a glance
- Drugs Rosiglitazone/metformin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 07 Jun 2017 Biomarkers information updated
- 01 Nov 2011 Efficacy and bone mineral density results published in Diabetes, Obesity and Metabolism.
- 24 Sep 2010 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History